| Document and Entity Information | 9 Months Ended |
| Mar. 31, 2014 | |
| Document And Entity Information | ' |
| Entity Registrant Name | 'Makism 3D Corp. |
| Entity Central Index Key | '0001495850 |
| Document Type | '10-Q |
| Document Period End Date | 31-Mar-14 |
| Amendment Flag | 'false |
| Current Fiscal Year End Date | '--06-30 |
| Is Entity a Well-known Seasoned Issuer? | 'No |
| Is Entity a Voluntary Filer? | 'No |
| Is Entity's Reporting Status Current? | 'Yes |
| Entity Filer Category | 'Smaller Reporting Company |
| Entity Common Stock, Shares Outstanding | 60,000,000 |
| Document Fiscal Period Focus | 'Q3 |
| Document Fiscal Year Focus | '2014 |
| Balance Sheets (USD $) | Mar. 31, 2014 | Jun. 30, 2013 |
| Current Assets: | ' | ' |
| Cash | $117,571 | ' |
| Receivables | 9,326 | ' |
| Prepaid expense | 4,343 | ' |
| Total current assets | 131,240 | ' |
| Non-current assets: | ' | ' |
| Machinery, net of accumulated depreciation of $1,272 | 27,050 | ' |
| Total assets | 158,290 | 0 |
| Current Liabilities: | ' | ' |
| Accounts payable | 24,487 | ' |
| Loans payable - director | 30,509 | ' |
| Total current liabilities | 54,996 | ' |
| Total liabilities | 54,996 | 0 |
| STOCKHOLDER'S DEFICIT: | ' | ' |
| Preferred stock, 50,000,000 shares authorized, par value $0.0001, no shares issued and outstanding | ' | ' |
| Common stock, 100,000,000 shares authorized, par value $0.0001, 60,000,000 and 27,000,000 shares issued and outstanding | 6,000 | 2,700 |
| Additional paid in capital | 502,429 | -2,700 |
| Deficit accumulated during the development stage | -405,135 | ' |
| Total stockholders' equity (deficit) | 103,294 | ' |
| Total liabilities and stockholders' deficit | $158,290 | $0 |
| Balance Sheets (Parenthetical) (USD $) | Mar. 31, 2014 | Jun. 30, 2013 |
| Balance Sheets Parenthetical | ' | ' |
| Accumulated depreciation | $1,272 | $1,272 |
| Preferred Stock shares authorized | 50,000,000 | 50,000,000 |
| Preferred Stock par value | $0.00 | $0.00 |
| Preferred Stock shares issued | 0 | 0 |
| Preferred Stock shares outstanding | 0 | 0 |
| Common Stock shares authorized | 100,000,000 | 100,000,000 |
| Common Stock par value | $0.00 | $0.00 |
| Common Stock shares issued | 60,000,000 | 27,000,000 |
| Common Stock shares outstanding | 60,000,000 | 27,000,000 |
| Statements of Operations (Unaudited) (USD $) | 3 Months Ended | 9 Months Ended | 47 Months Ended | ||
| Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | |
| Statements Of Operations | ' | ' | ' | ' | ' |
| Revenue | ' | ' | ' | ' | ' |
| Expenses: | ' | ' | ' | ' | ' |
| Operating expenses | 44,096 | ' | 405,135 | ' | 405,135 |
| Total expenses | 44,096 | ' | 405,135 | ' | 405,135 |
| Loss before income taxes | -44,096 | ' | -405,135 | ' | -405,135 |
| Provision for Income Taxes | ' | ' | ' | ' | ' |
| Net Loss | ($44,096) | ' | ($405,135) | $0 | ($405,135) |
| Basic and Diluted Loss per Common Share | $0 | ' | ($0.01) | ' | ' |
| Weighted Average number of Common Shares Outstanding | 58,200,000 | 70,000,000 | 44,803,000 | 70,000,000 | ' |
| Statements of Shareholders Equity (USD $) | Common Stock | Additional Paid-In Capital | Deficit Accumulated During the Development Stage | Total |
| Beginning Balance, Amount at May. 04, 2010 | ' | ' | ' | ' |
| Beginning Balance, Shares at May. 04, 2010 | ' | ' | ' | ' |
| Net loss | ' | ' | ' | ' |
| Ending Balance, Amount at Jun. 30, 2011 | ' | ' | ' | ' |
| Endiong Balance, Shares at Jun. 30, 2011 | ' | ' | ' | ' |
| Shares issued to founder, Amount | 2,700 | -2,700 | ' | ' |
| Shares issued to founder, Shares | 27,000,000 | ' | ' | ' |
| Ending Balance, Amount at Jun. 30, 2012 | 2,700 | -2,700 | ' | ' |
| Endiong Balance, Shares at Jun. 30, 2012 | 27,000,000 | ' | ' | ' |
| Net loss | ' | ' | ' | ' |
| Ending Balance, Amount at Jun. 30, 2013 | 2,700 | -2,700 | ' | ' |
| Endiong Balance, Shares at Jun. 30, 2013 | 27,000,000 | ' | ' | ' |
| Shares issued for consulting services, Amount | 280 | 395,359 | ' | 395,639 |
| Shares issued for consulting services, Shares | 2,800,000 | ' | ' | ' |
| Shares issued for services, Amount | 120 | 29,726 | ' | 29,846 |
| Shares issued for services, Shares | 1,200,000 | ' | ' | ' |
| Contributed Services | ' | 75,000 | ' | 75,000 |
| Shares deemed as issued to Makism sharehoders, Amount | 2,900 | -34,956 | ' | -32,056 |
| Shares deemed as issued to Makism sharehoders, Shares | 29,000,000 | ' | ' | ' |
| Net loss | ' | ' | -405,135 | -405,135 |
| Ending Balance, Amount at Mar. 31, 2014 | $6,000 | $462,429 | ($405,135) | $103,294 |
| Endiong Balance, Shares at Mar. 31, 2014 | 60,000,000 | ' | ' | ' |
| Statements of Cash Flows (Unaudited) (USD $) | 9 Months Ended | 47 Months Ended | |
| Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | |
| OPERATING ACTIVITIES | ' | ' | ' |
| Net Loss | ($405,135) | $0 | ($405,135) |
| Non cash items | ' | ' | ' |
| Consulting fees paid in stock | 29,846 | 0 | 29,846 |
| Contributed services | 75,000 | 0 | 75,000 |
| Amortization | 1,272 | 0 | 1,272 |
| Adjustments to Reconcile Net Loss to Net Cash Used by Operating Activities | ' | ' | ' |
| (Increase) decrease in receivables | -9,326 | 0 | -9,326 |
| (Increase) decrease in prepaid expenses | -4,343 | 0 | -4,343 |
| Increase (decrease) in accounts payable | 13,774 | 0 | 13,774 |
| Net cash used by operating activities | -298,912 | 0 | -298,912 |
| INVESTING ACTIVITIES | ' | ' | ' |
| Cash paid for purchase of fixed assets | -28,322 | 0 | -28,322 |
| Net cash used by investing activities | -28,322 | 0 | -28,322 |
| FINANCING ACTIVITIES | ' | ' | ' |
| Proceeds from (repayment of) loans - director | 9,166 | 0 | 9,166 |
| Proceeds from the sale of common stock | 435,639 | 0 | 435,639 |
| Net cash provided by financing activities | 444,805 | 0 | 444,805 |
| Net Increase (Decrease) in Cash | 117,571 | 0 | 117,571 |
| Cash, Beginning of Period | ' | 0 | ' |
| Cash, End of Period | 117,571 | 0 | 117,571 |
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | ' | ' | ' |
| Liabilities from reverse merger | 32,056 | 0 | 32,056 |
| Cash paid during the period for: | ' | ' | ' |
| Interest | ' | 0 | ' |
| Income taxes | ' | $0 | ' |
| Organization and Operations | 9 Months Ended |
| Mar. 31, 2014 | |
| Organization And Operations | ' |
| Note 1 - Organization and Operations | ' |
| Umicron Ltd., a development stage company, was incorporatedunder the laws of England and Wales. The Company intends to engage in the development and sale of 3D printers. | |
| On October 29, Umicron was combined with the public registered Company Makism 3D Corp, incorporated on May 4, 2010, in a transaction accounted for as a reverse merger. |
| Summary of Significant Accounting Policies | 9 Months Ended |
| Mar. 31, 2014 | |
| Summary Of Significant Accounting Policies | ' |
| Note 2 - Summary of Significant Accounting Policies | ' |
| Basis of Presentation | |
| The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Form 8-K filed with the SEC on November 4, 2013. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim period presented have been reflected herein. The results of operations for the interim period are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosures contained in the audited financial statements for the most recent fiscal period, as reported in the Form 8-K, have been omitted. | |
| Use of Estimates and Assumptions | |
| The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. | |
| Fiscal Year-End | |
| The Company elected June 30 as its fiscal year ending date. |
| Going Concern | 9 Months Ended |
| Mar. 31, 2014 | |
| Going Concern | ' |
| Note 3 - Going Concern | ' |
| As reflected in the financial statements, the Company had a deficit accumulated during the development stage at March 31, 2014, a net loss and net cash used in operating activities for the period from December 6, 2012 (inception) through March 31, 2014. These factors raise substantial doubt about the Company’s ability to continue as a going concern. In response to these conditions, we may raise additional capital through the sale of equity securities, through an offering of debt securities or through borrowings from financial institutions or individuals. The financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern. |
| Loans payable - director | 9 Months Ended |
| Mar. 31, 2014 | |
| Loans Payable - Director | ' |
| Note 4 - Loans payable - director | ' |
| The Company was advanced funds from a director to pay for operating expenses during the year. The advances are unsecured and payable on demand with no interest. At March 31, 2014, the company has $30,509 outstanding in loans payable to the director. |
| Common Stock | 9 Months Ended |
| Mar. 31, 2014 | |
| DisclosureCommonStockAbstract | ' |
| Note 5 - Common Stock | ' |
| On March 11, 2013, the Company issued 1,200,000 shares to two third parties for services with a total value of $29,846. During 2013, the Company sold 1,800,000 shares for total proceeds of $45,639. During 2013, various stockholders performed services for the Company valued at $75,000. | |
| On October 29, 2013, the Company issued 29,000,000 shares of common stock in exchange for 100% of the issued and outstanding shares of Umicron Ltd. | |
| On October 29, 2013, the Company cancelled 41,000,000 shares of common stock. | |
| On October 29, 2013, the Company issued 1,000,000 shares for $350,000 paid up front and another $250,000 due after the company has designed, manufactured, sold and delivered 10 3D printers. Should this event occur and the additional payment is not made, 500,000 of the shares must be returned and canceled. To date, the Company received an additional $40,000 which will be applied against the $250,000 due after the Company has achieved this milestone. |
| Reverse Merger | 9 Months Ended |
| Mar. 31, 2014 | |
| Notes to Financial Statements | ' |
| Note 6 - Reverse Merger | ' |
| On October 29, 2013, Makism 3D bought Umicron for 30,000,000 shares. As a result of the Exchange Transaction, the Selling Shareholders acquired approximately 50.67% of the companies issued and outstanding common stock in a reverse merger, Umicron became a wholly-owned subsidiary, and the Registrant acquired the business and operations of Umicron. In addition, the Company's former officer and director surrendered 41,000,000 shares. As such, immediately prior to the Exchange Transaction and after giving effect to the foregoing cancellations and issuances pursuant to the private placement offering described above, the Registrant had 70,000,000 shares outstanding. Immediately after the Exchange Transaction, the Registrant had 60,000,000 shares issued and outstanding. |
| Summary of Significant Accounting Policies (Policies) | 9 Months Ended |
| Mar. 31, 2014 | |
| Summary Of Significant Accounting Policies Policies | ' |
| Basis of Presentation | ' |
| The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Form 8-K filed with the SEC on November 4, 2013. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim period presented have been reflected herein. The results of operations for the interim period are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosures contained in the audited financial statements for the most recent fiscal period, as reported in the Form 8-K, have been omitted. | |
| Use of Estimates and Assumptions | ' |
| The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. | |
| Fiscal Year-End | ' |
| The Company elected June 30 as its fiscal year ending date. |
| Loans payable - director (Details Narrative) (USD $) | Mar. 31, 2014 | Jun. 30, 2013 |
| Loans Payable - Director Details Narrative | ' | ' |
| Loans payable - director | $30,509 | ' |
